Search Results - "Vegas, Adrián Sánchez"
-
1
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
Published in Breast (Edinburgh) (01-08-2021)“…Breast cancer is one of the most frequent malignancies. The aim of the article is to analyse the cost-utility ratio and budgetary impact of talazoparib…”
Get full text
Journal Article -
2
Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system
Published in The European journal of health economics (22-04-2024)“…Abemaciclib is an oral inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). Data from the clinical trial monarchE (2023) showed improved survival from…”
Get full text
Journal Article -
3
Third-line treatment and beyond in metastatic colorectal cancer: What do we have and what can we expect?
Published in Critical reviews in oncology/hematology (01-10-2024)“…Colorectal cancer remains the third most common cancer worldwide and the second cause of cancer-related death. Treatment advances and precision oncological…”
Get full text
Journal Article -
4
Neoplastic appendiceal mucinous lesions: a narrative review of the literature from an oncologist’s perspective
Published in Clinical & translational oncology (01-06-2024)“…Appendiceal mucinous lesions’ classification and nomenclature has been modified several times along the last decades, reflecting their great heterogeneity and…”
Get full text
Journal Article -
5
Analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with carboplatin-paclitaxel after multiple lines of treatment
Published in Journal of clinical oncology (01-02-2024)“…144 Background: Metastatic castration-resistant prostate cancer (mCRPC) occurs in men with advanced disease progressing to androgen deprivation therapy, with…”
Get full text
Journal Article